{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:17Z","timestamp":1786984997330,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CBB-APQ-03242-16"],"award-info":[{"award-number":["CBB-APQ-03242-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309122\/2019-8"],"award-info":[{"award-number":["309122\/2019-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["421021\/2016-0"],"award-info":[{"award-number":["421021\/2016-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bbapap.2021.140622","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:44:52Z","timestamp":1613565892000},"page":"140622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pathological cardiac remodeling seen by the eyes of proteomics"],"prefix":"10.1016","volume":"1869","author":[{"given":"Diana Paola","family":"G\u00f3mez-Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Lara-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Verano-Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2021.140622_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"Cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbapap.2021.140622_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12967-018-1476-9","article-title":"Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease","volume":"16","author":"Lygirou","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbapap.2021.140622_bb0015","article-title":"S. Stroke Statistics, Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association","volume":"133","author":"M. Writing Group","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","article-title":"Metabolic coordination of physiological and pathological cardiac remodeling","volume":"123","author":"Gibb","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0035","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2021.140622_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","article-title":"Mechanisms for the transition from physiological to pathological cardiac hypertrophy","volume":"98","author":"Oldfield","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.bbapap.2021.140622_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00424-014-1480-8","article-title":"Heart failure with preserved ejection fraction","volume":"466","author":"Gladden","year":"2014","journal-title":"Pflugers Archiv : European journal of physiology"},{"key":"10.1016\/j.bbapap.2021.140622_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","article-title":"Myocardial remodeling after infarction: the role of myofibroblasts","volume":"7","author":"van den Borne","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0070","first-page":"61","article-title":"From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis","volume":"14","author":"Wilkins","year":"1996","journal-title":"Biotechnology"},{"key":"10.1016\/j.bbapap.2021.140622_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature01510","article-title":"From genomics to proteomics","volume":"422","author":"Tyers","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2021.140622_bb0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.1124619","article-title":"Mass spectrometry and protein analysis","volume":"312","author":"Domon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2021.140622_bb0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature01511","article-title":"Mass spectrometry-based proteomics","volume":"422","author":"Aebersold","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2021.140622_bb0090","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/pmic.200401308","article-title":"Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase","volume":"5","author":"Berhane","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.bbapap.2021.140622_bb0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0100","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41467-017-01747-2","article-title":"Region and cell-type resolved quantitative proteomic map of the human heart","volume":"8","author":"Doll","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbapap.2021.140622_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt0303-255","article-title":"Proteomic analysis of post-translational modifications","volume":"21","author":"Mann","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/gm424","article-title":"Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics","volume":"5","author":"Liddy","year":"2013","journal-title":"Genome Medicine"},{"key":"10.1016\/j.bbapap.2021.140622_bb0115","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1021\/pr200258m","article-title":"Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure","volume":"10","author":"Zhang","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0120","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10741-010-9181-7","article-title":"Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities","volume":"16","author":"Gajarsa","year":"2011","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bbapap.2021.140622_bb0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvs018","article-title":"The innate immune response in reperfused myocardium","volume":"94","author":"Timmers","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0135","doi-asserted-by":"crossref","first-page":"H2805","DOI":"10.1152\/ajpheart.00299.2008","article-title":"Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion","volume":"294","author":"Zou","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0140","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2012-10-460360","article-title":"Prolylcarboxypeptidase promotes angiogenesis and vascular repair","volume":"122","author":"Adams","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2021.140622_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbamcr.2012.08.023","article-title":"Fibroblasts in post-infarction inflammation and cardiac repair","volume":"1833","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2021.140622_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41420-019-0152-z","article-title":"The whole transcriptome and proteome changes in the early stage of myocardial infarction","volume":"5","author":"Li","year":"2019","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.bbapap.2021.140622_bb0160","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/acs.jproteome.7b00107","article-title":"Quantitative proteomics and immunohistochemistry reveal insights into cellular and molecular processes in the infarct border zone one month after myocardial infarction","volume":"16","author":"Yang","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0165","doi-asserted-by":"crossref","first-page":"H475","DOI":"10.1152\/ajpheart.00360.2002","article-title":"Border zone geometry increases wall stress after myocardial infarction: contrast echocardiographic assessment","volume":"284","author":"Jackson","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jprot.2016.11.017","article-title":"Quantitative proteomic changes during post myocardial infarction remodeling reveals altered cardiac metabolism and Desmin aggregation in the infarct region","volume":"152","author":"Datta","year":"2017","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbapap.2021.140622_bb0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-014-2016-4","article-title":"Desmin in muscle and associated diseases: beyond the structural function","volume":"360","author":"Hnia","year":"2015","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0180","doi-asserted-by":"crossref","first-page":"103486","DOI":"10.1016\/j.jprot.2019.103486","article-title":"Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4","volume":"208","author":"Gomez-Mendoza","year":"2019","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbapap.2021.140622_bb0185","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","article-title":"RhoA\/rho-kinase in the cardiovascular system","volume":"118","author":"Shimokawa","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0190","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1253\/circj.CJ-13-0397","article-title":"Rho-kinase activation in patients with heart failure","volume":"77","author":"Do","year":"2013","journal-title":"Circulation J."},{"key":"10.1016\/j.bbapap.2021.140622_bb0195","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nbt.2356","article-title":"Selective enrichment of newly synthesized proteins for quantitative secretome analysis","volume":"30","author":"Eichelbaum","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0200","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/CIRCULATIONAHA.119.044914","article-title":"Secretome analysis of cardiomyocytes identifies PCSK6 (Proprotein convertase Subtilisin\/Kexin type 6) as a novel player in cardiac remodeling after myocardial infarction","volume":"141","author":"Kuhn","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0205","first-page":"1113","article-title":"Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling","volume":"466","author":"Ma","year":"2014","journal-title":"Pflugers Archiv : European journal of physiology"},{"key":"10.1016\/j.bbapap.2021.140622_bb0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/prca.201500030","article-title":"Cardiac extracellular matrix proteomics: challenges, techniques, and clinical implications","volume":"10","author":"Chang","year":"2016","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbapap.2021.140622_bb0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.111.056952","article-title":"Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia\/reperfusion injury","volume":"125","author":"Barallobre-Barreiro","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0220","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","article-title":"Extracellular matrix remodeling and cardiac fibrosis","volume":"68-69","author":"Li","year":"2018","journal-title":"Matrix Biology"},{"key":"10.1016\/j.bbapap.2021.140622_bb0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0230","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.yjmcc.2009.06.012","article-title":"Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences","volume":"48","author":"Zamilpa","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0235","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/eurheartj\/ehn315","article-title":"Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction","volume":"29","author":"Kelly","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbapap.2021.140622_bb0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yjmcc.2018.07.126","article-title":"Quantitative temporal analysis of protein dynamics in cardiac remodeling","volume":"121","author":"McClatchy","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-017-02467-3","article-title":"Integrated omics dissection of proteome dynamics during cardiac remodeling","volume":"9","author":"Lau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbapap.2021.140622_bb0250","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1139\/y84-061","article-title":"Development of isoproterenol-induced cardiac hypertrophy","volume":"62","author":"Taylor","year":"1984","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yjmcc.2012.09.002","article-title":"Mitochondria in cardiac hypertrophy and heart failure","volume":"55","author":"Rosca","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0265","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 Inflammasome activation initiated in response to pressure overload by ca(2+)\/calmodulin-dependent protein kinase II delta signaling in cardiomyocytes are essential for adverse cardiac remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0270","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCRESAHA.118.312708","article-title":"Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure","volume":"123","author":"Dey","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0275","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008441","article-title":"Relaxin family member insulin-like peptide 6 ameliorates cardiac fibrosis and prevents cardiac remodeling in murine heart failure models","volume":"7","author":"Maruyama","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.bbapap.2021.140622_bb0280","article-title":"Cardiomyocyte proteome remodeling due to isoproterenol-induced cardiac hypertrophy during the compensated phase","volume":"14","author":"Parreira","year":"2020","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbapap.2021.140622_bb0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fphar.2014.00224","article-title":"Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology","volume":"5","author":"Wani","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0290","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.jproteome.8b00372","article-title":"Integrated dissection of cysteine oxidative post-translational modification proteome during cardiac hypertrophy","volume":"17","author":"Wang","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0295","series-title":"BEST (Biomarkers, EndpointS, and Other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2016"},{"key":"10.1016\/j.bbapap.2021.140622_bb0300","doi-asserted-by":"crossref","first-page":"IV31","DOI":"10.1161\/01.CIR.0000133442.99186.39","article-title":"Surrogate markers for cardiovascular disease: functional markers","volume":"109","author":"Cohn","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0305","doi-asserted-by":"crossref","first-page":"IV22","DOI":"10.1161\/01.CIR.0000133443.77237.2f","article-title":"Surrogate markers for cardiovascular disease: structural markers","volume":"109","author":"Mancini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0310","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1373\/49.8.1258","article-title":"Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment","volume":"49","author":"Ledue","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbapap.2021.140622_bb0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"Melander","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.bbapap.2021.140622_bb0320","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008108","article-title":"Protein biomarkers of cardiovascular disease and mortality in the community","volume":"7","author":"Ho","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.bbapap.2021.140622_bb0325","doi-asserted-by":"crossref","first-page":"942","DOI":"10.15252\/msb.20156297","article-title":"Revisiting biomarker discovery by plasma proteomics","volume":"13","author":"Geyer","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0330","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/pmic.200700781","article-title":"Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis","volume":"8","author":"Pinet","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bbapap.2021.140622_bb0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma proteome profiling to assess human health and disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Systems"},{"key":"10.1016\/j.bbapap.2021.140622_bb0340","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acs.jproteome.7b00651","article-title":"Myocardial injury is distinguished from stable angina by a set of candidate plasma biomarkers identified using iTRAQ\/MRM-based approach","volume":"17","author":"Cheow","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0345","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.116.021803","article-title":"Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease","volume":"134","author":"Ngo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0350","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbapap.2021.140622_bb0355","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0360","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/CS20120461","article-title":"Angiotensin-(1-7): beyond the cardio-renal actions","volume":"124","author":"Passos-Silva","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbapap.2021.140622_bb0365","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and mas: new players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0370","first-page":"160","article-title":"Direct renin inhibitor attenuates left ventricular remodeling in post-myocardial infarction heart failure mice","volume":"29","author":"Yang","year":"2013","journal-title":"Acta Cardiologica Sinica"},{"key":"10.1016\/j.bbapap.2021.140622_bb0375","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.yjmcc.2015.10.022","article-title":"A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes","volume":"89","author":"Lyu","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11906-010-0091-9","article-title":"The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point","volume":"12","author":"Sica","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbapap.2021.140622_bb0385","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets","volume":"186","author":"Mirabito Colafella","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0390","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/HYPERTENSIONAHA.111.179457","article-title":"Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy","volume":"59","author":"Finckenberg","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bbapap.2021.140622_bb0395","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0400","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","article-title":"Counterregulatory actions of angiotensin-(1-7)","volume":"30","author":"Ferrario","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.bbapap.2021.140622_bb0405","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1042\/CS20200478","article-title":"ACE2 in the renin-angiotensin system","volume":"134","author":"Verano-Braga","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbapap.2021.140622_bb0410","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circulation research"},{"key":"10.1016\/j.bbapap.2021.140622_bb0415","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbapap.2021.140622_bb0420","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbapap.2021.140622_bb0425","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/HYPERTENSIONAHA.120.15829","article-title":"Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure","volume":"76","author":"Chirinos","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.bbapap.2021.140622_bb0430","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057111413919","article-title":"Prediction of off-target effects on angiotensin-converting enzyme 2","volume":"16","author":"Kulemina","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbapap.2021.140622_bb0435","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hernandez Prada","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.bbapap.2021.140622_bb0440","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clinical autonomic research : official journal of the Clinical Autonomic Research Society"},{"key":"10.1016\/j.bbapap.2021.140622_bb0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40264-014-0239-7","article-title":"The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases","volume":"38","author":"Abraham","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.bbapap.2021.140622_bb0450","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0455","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10557-012-6392-2","article-title":"ARB and cardioprotection","volume":"27","author":"Akazawa","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbapap.2021.140622_bb0460","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/B:MCBI.0000041860.97991.7a","article-title":"AT1receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics","volume":"263","author":"Jugdutt","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbapap.2021.140622_bb0465","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13105-010-0039-1","article-title":"Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan--a proteomic analysis","volume":"66","author":"Liu","year":"2010","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.bbapap.2021.140622_bb0470","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.110.167346","article-title":"An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats","volume":"57","author":"Marques","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bbapap.2021.140622_bb0475","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1054-3589(10)59007-0","article-title":"Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)","volume":"59","author":"Ferrario","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0480","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/pr3001755","article-title":"Time-resolved quantitative phosphoproteomics: new insights into angiotensin-(1-7) signaling networks in human endothelial cells","volume":"11","author":"Verano-Braga","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbapap.2021.140622_bb0485","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.106.637124","article-title":"Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling","volume":"114","author":"Ni","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbapap.2021.140622_bb0490","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fca.12.75","article-title":"Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system","volume":"9","author":"Clarke","year":"2013","journal-title":"Futur. Cardiol."},{"key":"10.1016\/j.bbapap.2021.140622_bb0495","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.bbapap.2013.08.008","article-title":"The influence of angiotensin-(1-7) mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice","volume":"1834","author":"Suski","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2021.140622_bb0500","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1755-5922.2010.00255.x","article-title":"Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991","volume":"30","author":"Zeng","year":"2012","journal-title":"Cardiovasc. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963921000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963921000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:54:18Z","timestamp":1761609258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963921000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1570963921000285"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2021.140622","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological cardiac remodeling seen by the eyes of proteomics","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2021.140622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"140622"}}